Clinical Trials Directory

Trials / Completed

CompletedNCT00473057

Study of Autologous Stem Cell Transplantation for Patients With Ischemic Stroke

Phase I Study of Autologous Bone Marrow Cell Transplantation in Patient With Ischemic Stroke

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Universidade Federal do Rio de Janeiro · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This is a open label study to assess the safety of autologous bone marrow transplantation in patients with a ischemic stroke in the middle cerebral artery territory within 90 days from symptoms onset.

Detailed description

Objective: The purpose of this study is to evaluate the safety and feasibility of intra-arterial and intravenous injection of autologous bone marrow mononuclear cells in patients in the acute and sub-acute phase (\> 3 and \< 90 days after symptoms onset) of ischemic cerebral infarct in the middle cerebral artery territory. Methods: 15 patients with cerebral infarct within the middle cerebral artery territory will be enrolled in this prospective, nonrandomized, open-labeled study. Up to 10 patients will receive up to 500x 10 6 autologous bone marrow cells injected intra-arterially into the middle cerebral artery through percutaneous approach. The procedure is monitored by Transcranial Doppler (TCD) and electroencephalogram (EEG). Other 5 patients will receive up to 500x 10 6 autologous bone marrow cells injected intravenously. Changes in neurological deficits and improvements in functions will be evaluated at baseline and at regular intervals during follow-up ( 4 months). EEG and neuroimaging exams will be performed at baseline and at regular intervals during the follow-up period.

Conditions

Interventions

TypeNameDescription
OTHERAutologous cell transplantationIntra-arterial or intravenous delivery of autologous bone marrow cells

Timeline

Start date
2005-12-01
Primary completion
2011-05-01
Completion
2011-05-01
First posted
2007-05-14
Last updated
2011-05-19

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT00473057. Inclusion in this directory is not an endorsement.